Bottom line
GNOM vs FBDIX: the short answer
GNOM (Global X Genomics & Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are both etfs.
But FBDIX is far broader, holding 126 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.
GNOM is cheaper at 0.5% vs 1.01% — a difference of $51 a year per $10,000 invested.
Over five years, FBDIX returned +5.0% a year vs −13.3% for GNOM.
FBDIX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
GNOM vs FBDIX side by side
| GNOM | FBDIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Global X | Franklin Templeton |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.5% | 1.01% |
| Annual cost per $10k | $50 | $101 |
| 10-yr cost on $10k (prospectus) | $628 | $1,728 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +19.0% | +43.9% |
| 5-yr return (annualized) | −13.3% | +5.0% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +38.8% | +29.5% |
| Worst quarter | −24.2% | −24.5% |
| Net assets (fund) | $55.8M | $1.2B |
| Number of holdings | 51 | 126 |
| Portfolio turnover | 34% | 38% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GNOM | FBDIX | Difference |
|---|---|---|---|
| 2025 | +19.0% | +52.3% | −33.3% |
| 2024 | −16.2% | +4.0% | −20.2% |
| 2023 | −8.6% | +18.4% | −27.0% |
| 2022 | −36.1% | −12.7% | −23.4% |
| 2021 | −16.0% | −17.7% | +1.7% |
| 2020 | +51.6% | +29.9% | +21.7% |
Source: Fund prospectus bar charts
Holdings overlap
6 of GNOM's top 25 holdings also appear in FBDIX's top 25.
| Holding | GNOM | FBDIX |
|---|---|---|
| Guardant Health, Inc. | 5.59% | 2.76% |
| Praxis Precision Medicines Inc | 4.01% | 1.91% |
| Vertex Pharmaceuticals Incorporated | 3.95% | 3.54% |
| Eli Lilly And Company | 2.32% | 1.31% |
| Gilead Sciences, Inc. | 1.95% | 3.86% |
| Astrazeneca Plc | 1.83% | 1.51% |
Source: SEC Form N-PORT
GNOM top 10
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Natera, Inc. — 4.15%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
FBDIX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FAQ
What is the difference between GNOM and FBDIX?
Which is cheaper, GNOM or FBDIX?
Should I own both GNOM and FBDIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.